Zobrazeno 1 - 10 of 67 pro vyhledávání: '"Mitra Ghosh T"'
1
Akademický článek
Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial-mesenchymal Transition in Aggressive Variant Prostate Cancers.
Autor: Mitra Ghosh T; Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, Alabama.; Division of Urology, Department of Surgery, Mass General Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Mazumder S; Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, Alabama.; Center for Pharmacogenomics and Single-Cell Omics (AUPharmGx), Harrison College of Pharmacy, Auburn University, Auburn, Alabama., Davis J; Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, Alabama., Yadav J; Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, Alabama., Akinpelu A; Department of Chemical Engineering, Samuel Ginn College of Engineering, Auburn University, Auburn, Alabama., Alnaim A; Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, Alabama., Kumar H; Department of Biology and Canter for Cancer Research, Tuskegee University, Tuskegee, Alabama., Waliagha R; Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, Alabama., Church Bird AE; Flow Cytometry and High-Speed Cell Sorting Laboratory, Auburn University, Auburn, Alabama., Rais-Bahrami S; UAB O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama.; Department of Urology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama.; Department of Radiology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama.; Department of Pathology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama., Bird RC; Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, Alabama., Mistriotis P; Department of Chemical Engineering, Samuel Ginn College of Engineering, Auburn University, Auburn, Alabama., Mishra A; Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, Alabama., Yates CC; Department of Biology and Canter for Cancer Research, Tuskegee University, Tuskegee, Alabama.; UAB O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama.; Department of Pathology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Mitra AK; Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, Alabama.; Center for Pharmacogenomics and Single-Cell Omics (AUPharmGx), Harrison College of Pharmacy, Auburn University, Auburn, Alabama.; UAB O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama., Arnold RD; Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, Alabama.; Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, Alabama.; UAB O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama.
Publikováno v: Cancer research communications [Cancer Res Commun] 2023 Jul 19; Vol. 3 (7), pp. 1286-1311. Date of Electronic Publication: 2023 Jul 19 (Print Publication: 2023).
Zobrazit plný text záznamu
2
Akademický článek
Integrating Pharmacogenomics Data-Driven Computational Drug Prediction with Single-Cell RNAseq to Demonstrate the Efficacy of a NAMPT Inhibitor against Aggressive, Taxane-Resistant, and Stem-like Cells in Lethal Prostate Cancer.
Autor: Mazumder S; Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA.; Center for Pharmacogenomics and Single-Cell Omics (AUPharmGx), Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA., Mitra Ghosh T; Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA.; Department of Urology Research, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA., Mukherjee UK; Department of Business Administration, University of Illinois at Urbana-Champaign, Champaign, IL 61820, USA.; Biomedical and Translational Sciences, Carle Illinois College of Medicine, University of Illinois Urbana-Champaign, Champaign, IL 61820, USA., Chakravarti S; Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA., Amiri F; Department of Chemical Engineering, Samuel Ginn College of Engineering, Auburn University, Auburn, AL 36849, USA., Waliagha RS; Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA., Hemmati F; Department of Chemical Engineering, Samuel Ginn College of Engineering, Auburn University, Auburn, AL 36849, USA., Mistriotis P; Department of Chemical Engineering, Samuel Ginn College of Engineering, Auburn University, Auburn, AL 36849, USA., Ahmed S; Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA.; Center for Pharmacogenomics and Single-Cell Omics (AUPharmGx), Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA., Elhussin I; Department of Biology and Canter for Cancer Research, Tuskegee University, Tuskegee, AL 36088, USA., Salam AB; Department of Biology and Canter for Cancer Research, Tuskegee University, Tuskegee, AL 36088, USA., Dean-Colomb W; Department of Biology and Canter for Cancer Research, Tuskegee University, Tuskegee, AL 36088, USA.; Piedmont Hospital, Newnan, GA 30309, USA., Yates C; Department of Biology and Canter for Cancer Research, Tuskegee University, Tuskegee, AL 36088, USA.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21218, USA.; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21218, USA.; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD 21218, USA.; UAB O'Neal Comprehensive Cancer, University of Alabama at Birmingham School of Medicine, Birmingham, AL 35233, USA., Arnold RD; Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA.; UAB O'Neal Comprehensive Cancer, University of Alabama at Birmingham School of Medicine, Birmingham, AL 35233, USA., Mitra AK; Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA.; Center for Pharmacogenomics and Single-Cell Omics (AUPharmGx), Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA.; UAB O'Neal Comprehensive Cancer, University of Alabama at Birmingham School of Medicine, Birmingham, AL 35233, USA.
Publikováno v: Cancers [Cancers (Basel)] 2022 Dec 06; Vol. 14 (23). Date of Electronic Publication: 2022 Dec 06.
Zobrazit plný text záznamu
3
Akademický článek
The Andrographolide Analogue 3A.1 Synergizes with Taxane Derivatives in Aggressive Metastatic Prostate Cancers by Upregulation of Heat Shock Proteins and Downregulation of MAT2A-Mediated Cell Migration and Invasion.
Autor: Mitra Ghosh T; Department of Drug Discovery and Development, Harrison School of Pharmacy (T.M.G., T.K., S.M., J.D., A.S.A., S.L.J., C.Z., A.B., A.K.M., R.D.A.) and Center for Pharmacogenomics and Single-Cell Omics Initiative (S.M., A.K.M.), Auburn University, Auburn, Alabama; Department of Pharmaceutical Technology, Faculty of Pharmacy, Silpakorn University, Bangkok, Thailand (T.K., P.O.); and University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham, Alabama (A.K.M., R.D.A.)., Kansom T; Department of Drug Discovery and Development, Harrison School of Pharmacy (T.M.G., T.K., S.M., J.D., A.S.A., S.L.J., C.Z., A.B., A.K.M., R.D.A.) and Center for Pharmacogenomics and Single-Cell Omics Initiative (S.M., A.K.M.), Auburn University, Auburn, Alabama; Department of Pharmaceutical Technology, Faculty of Pharmacy, Silpakorn University, Bangkok, Thailand (T.K., P.O.); and University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham, Alabama (A.K.M., R.D.A.)., Mazumder S; Department of Drug Discovery and Development, Harrison School of Pharmacy (T.M.G., T.K., S.M., J.D., A.S.A., S.L.J., C.Z., A.B., A.K.M., R.D.A.) and Center for Pharmacogenomics and Single-Cell Omics Initiative (S.M., A.K.M.), Auburn University, Auburn, Alabama; Department of Pharmaceutical Technology, Faculty of Pharmacy, Silpakorn University, Bangkok, Thailand (T.K., P.O.); and University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham, Alabama (A.K.M., R.D.A.)., Davis J; Department of Drug Discovery and Development, Harrison School of Pharmacy (T.M.G., T.K., S.M., J.D., A.S.A., S.L.J., C.Z., A.B., A.K.M., R.D.A.) and Center for Pharmacogenomics and Single-Cell Omics Initiative (S.M., A.K.M.), Auburn University, Auburn, Alabama; Department of Pharmaceutical Technology, Faculty of Pharmacy, Silpakorn University, Bangkok, Thailand (T.K., P.O.); and University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham, Alabama (A.K.M., R.D.A.)., Alnaim AS; Department of Drug Discovery and Development, Harrison School of Pharmacy (T.M.G., T.K., S.M., J.D., A.S.A., S.L.J., C.Z., A.B., A.K.M., R.D.A.) and Center for Pharmacogenomics and Single-Cell Omics Initiative (S.M., A.K.M.), Auburn University, Auburn, Alabama; Department of Pharmaceutical Technology, Faculty of Pharmacy, Silpakorn University, Bangkok, Thailand (T.K., P.O.); and University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham, Alabama (A.K.M., R.D.A.)., Jasper SL; Department of Drug Discovery and Development, Harrison School of Pharmacy (T.M.G., T.K., S.M., J.D., A.S.A., S.L.J., C.Z., A.B., A.K.M., R.D.A.) and Center for Pharmacogenomics and Single-Cell Omics Initiative (S.M., A.K.M.), Auburn University, Auburn, Alabama; Department of Pharmaceutical Technology, Faculty of Pharmacy, Silpakorn University, Bangkok, Thailand (T.K., P.O.); and University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham, Alabama (A.K.M., R.D.A.)., Zhang C; Department of Drug Discovery and Development, Harrison School of Pharmacy (T.M.G., T.K., S.M., J.D., A.S.A., S.L.J., C.Z., A.B., A.K.M., R.D.A.) and Center for Pharmacogenomics and Single-Cell Omics Initiative (S.M., A.K.M.), Auburn University, Auburn, Alabama; Department of Pharmaceutical Technology, Faculty of Pharmacy, Silpakorn University, Bangkok, Thailand (T.K., P.O.); and University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham, Alabama (A.K.M., R.D.A.)., Bird A; Department of Drug Discovery and Development, Harrison School of Pharmacy (T.M.G., T.K., S.M., J.D., A.S.A., S.L.J., C.Z., A.B., A.K.M., R.D.A.) and Center for Pharmacogenomics and Single-Cell Omics Initiative (S.M., A.K.M.), Auburn University, Auburn, Alabama; Department of Pharmaceutical Technology, Faculty of Pharmacy, Silpakorn University, Bangkok, Thailand (T.K., P.O.); and University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham, Alabama (A.K.M., R.D.A.)., Opanasopit P; Department of Drug Discovery and Development, Harrison School of Pharmacy (T.M.G., T.K., S.M., J.D., A.S.A., S.L.J., C.Z., A.B., A.K.M., R.D.A.) and Center for Pharmacogenomics and Single-Cell Omics Initiative (S.M., A.K.M.), Auburn University, Auburn, Alabama; Department of Pharmaceutical Technology, Faculty of Pharmacy, Silpakorn University, Bangkok, Thailand (T.K., P.O.); and University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham, Alabama (A.K.M., R.D.A.)., Mitra AK; Department of Drug Discovery and Development, Harrison School of Pharmacy (T.M.G., T.K., S.M., J.D., A.S.A., S.L.J., C.Z., A.B., A.K.M., R.D.A.) and Center for Pharmacogenomics and Single-Cell Omics Initiative (S.M., A.K.M.), Auburn University, Auburn, Alabama; Department of Pharmaceutical Technology, Faculty of Pharmacy, Silpakorn University, Bangkok, Thailand (T.K., P.O.); and University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham, Alabama (A.K.M., R.D.A.)., Arnold RD; Department of Drug Discovery and Development, Harrison School of Pharmacy (T.M.G., T.K., S.M., J.D., A.S.A., S.L.J., C.Z., A.B., A.K.M., R.D.A.) and Center for Pharmacogenomics and Single-Cell Omics Initiative (S.M., A.K.M.), Auburn University, Auburn, Alabama; Department of Pharmaceutical Technology, Faculty of Pharmacy, Silpakorn University, Bangkok, Thailand (T.K., P.O.); and University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham, Alabama (A.K.M., R.D.A.) rda0007@auburn.edu.
Publikováno v: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2022 Mar; Vol. 380 (3), pp. 180-201. Date of Electronic Publication: 2021 Dec 23.
Zobrazit plný text záznamu
4
Akademický článek
Identification and Characterization of Key Differentially Expressed Genes Associated With Metronomic Dosing of Topotecan in Human Prostate Cancer.
Autor: Mitra Ghosh T; Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, United States., White J; Department of Biology and Center for Cancer Research, Tuskegee University, Tuskegee, AL, United States., Davis J; Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, United States., Mazumder S; Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, United States.; Center for Pharmacogenomics and Single-Cell Omics, Auburn University, Auburn, AL, United States., Kansom T; Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, United States., Skarupa E; Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, United States., Barnett GS; Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, United States., Piazza GA; Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, United States., Bird RC; Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL, United States., Mitra AK; Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, United States.; Center for Pharmacogenomics and Single-Cell Omics, Auburn University, Auburn, AL, United States.; UAB O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham School of Medicine, Birmingham, AL, United States., Yates C; Department of Biology and Center for Cancer Research, Tuskegee University, Tuskegee, AL, United States.; UAB O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham School of Medicine, Birmingham, AL, United States.; Department of Pathology, University of Alabama at Birmingham School of Medicine, Birmingham, AL, United States., Cummings BS; Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, United States., Arnold RD; Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, United States.; Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL, United States.; UAB O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham School of Medicine, Birmingham, AL, United States.
Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2021 Dec 06; Vol. 12, pp. 736951. Date of Electronic Publication: 2021 Dec 06 (Print Publication: 2021).
Zobrazit plný text záznamu
5
Akademický článek
PharmGKB summary: lamotrigine pathway, pharmacokinetics and pharmacodynamics.
Autor: Mitra-Ghosh T; Department of Experimental and Clinical Pharmacology, University of Minnesota Minneapolis., Callisto SP; Department of Experimental and Clinical Pharmacology, University of Minnesota Minneapolis., Lamba JK; Department of Pharmacotherapy and Translational Research, University of Florida Gainesville, Florida., Remmel RP; Department of Experimental and Clinical Pharmacology, University of Minnesota Minneapolis., Birnbaum AK; Department of Experimental and Clinical Pharmacology, University of Minnesota Minneapolis., Barbarino JM; Departments of Biomedical Data Sciences., Klein TE; Departments of Biomedical Data Sciences.; Medicine., Altman RB; Departments of Biomedical Data Sciences.; Medicine.; Biomedical Engineering.; Genetics, Stanford University, California, USA, Taraswi Mitra-Ghosh is now with the Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, Alabama, USA.
Publikováno v: Pharmacogenetics and genomics [Pharmacogenet Genomics] 2020 Jun; Vol. 30 (4), pp. 81-90.
Zobrazit plný text záznamu
7
Akademický článek
Computational drug discovery pipelines identify NAMPT as a therapeutic target in neuroendocrine prostate cancer.
Autor: Zhang, Weijie1,2 (AUTHOR), Lee, Adam2 (AUTHOR), Lee, Lauren2 (AUTHOR), Dehm, Scott M.3,4,5 (AUTHOR), Huang, R. Stephanie1,2,3 (AUTHOR) rshuang@umn.edu
Publikováno v: CTS: Clinical & Translational Science. Sep2024, Vol. 17 Issue 9, p1-16. 16p.
Zobrazit plný text záznamu
8
Akademický článek
From Drug Discovery to Drug Approval: A Comprehensive Review of the Pharmacogenomics Status Quo with a Special Focus on Egypt.
Autor: Elgarhy, Fadya M.1,2 (AUTHOR) fadya_elgarhy@aucegypt.edu, Borham, Abdallah1 (AUTHOR) abdallahborham@aucegypt.edu, Alziny, Noha1 (AUTHOR) nohaalziny@aucegypt.edu, AbdElaal, Khlood R.3 (AUTHOR) khlood.ramadan@aucegypt.edu, Shuaib, Mahmoud1 (AUTHOR) mahmoudshuaib@aucegypt.edu, Musaibah, Abobaker Salem1 (AUTHOR) abobaker@aucegypt.edu, Hussein, Mohamed Ali1 (AUTHOR) mohamed_hussein@aucegypt.edu, Abdelnaser, Anwar1 (AUTHOR) anwar.abdelnaser@aucegypt.edu
Publikováno v: Pharmaceuticals (14248247). Jul2024, Vol. 17 Issue 7, p881. 22p.
Zobrazit plný text záznamu
9
Akademický článek
Pharmacokinetic Simulation Study: Exploring the Impact of Clinical Parameters on Lamotrigine for Different Patient Populations with Implications for Liver Function Assessment and Therapeutic Drug Monitoring.
Autor: Costa, Bárbara1,2,3 (AUTHOR) b.c.211297@gmail.com, Silva, Isabel4 (AUTHOR) isa_camp_sil@hotmail.com, Oliveira, José Carlos4,5 (AUTHOR) director.sqc@chporto.min-saude.pt, Reguengo, Henrique4,5 (AUTHOR) hlreguengo@gmail.com, Vale, Nuno1,2,3 (AUTHOR) nunovale@med.up.pt
Publikováno v: Scientia Pharmaceutica. Mar2024, Vol. 92 Issue 1, p15. 23p.
Zobrazit plný text záznamu
10
Akademický článek
Addressing Genetic Tumor Heterogeneity, Post-Therapy Metastatic Spread, Cancer Repopulation, and Development of Acquired Tumor Cell Resistance.
Autor: Harrer, Dennis Christoph1 (AUTHOR) dennis.harrer@ukr.de, Lüke, Florian1,2 (AUTHOR) florian.lueke@ukr.de, Pukrop, Tobias1,3 (AUTHOR) tobias.pukrop@ukr.de, Ghibelli, Lina4 (AUTHOR) ghibelli@uniroma2.it, Reichle, Albrecht1 (AUTHOR) albrecht.reichle@ukr.de, Heudobler, Daniel1,3 (AUTHOR)
Publikováno v: Cancers. Jan2024, Vol. 16 Issue 1, p180. 22p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje